Syntheses and antiproliferative evaluation of 6-thienyl, 6-polyphenyl aryl and 6-naphthyl derivatives of 2,4-diaminopyrido[3,2-d]pyramidine as non-classical antifolate targeting DHFR

[1]  M. Wang,et al.  Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase. , 2017, European journal of medicinal chemistry.

[2]  Hongliang Yang,et al.  Synthesis, preliminary structure-activity relationships and biological evaluation of pyridinyl-4,5-2H-isoxazole derivatives as potent antitumor agents , 2017, Chemical Research in Chinese Universities.

[3]  Junyi Liu,et al.  A convenient one-pot process for the synthesis of 2,4-dihydroxy-6-phenylethylenyl-8-deazapteridine derivatives , 2016 .

[4]  N. Priestley,et al.  Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens. , 2016, ACS medicinal chemistry letters.

[5]  Ghada S. Hassan,et al.  Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors. , 2014, Bioorganic & medicinal chemistry letters.

[6]  C. Frei,et al.  Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections , 2010, The Journal of the American Board of Family Medicine.

[7]  Ebtehal S. Al-Abdullah,et al.  Synthesis, Antimicrobial, and Anti-inflammatory Activities of Novel 5-(1-Adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and Related Derivatives , 2010, Molecules.

[8]  N. Priestley,et al.  Probing the Active Site of Candida glabrata Dihydrofolate Reductase with High Resolution Crystal Structures and the Synthesis of New Inhibitors , 2009, Chemical biology & drug design.

[9]  Erin S. Bolstad,et al.  Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium. , 2008, Journal of medicinal chemistry.

[10]  Peter E Wright,et al.  Structure, dynamics, and catalytic function of dihydrofolate reductase. , 2004, Annual review of biophysics and biomolecular structure.

[11]  J. Kublin,et al.  Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study , 2004, BMJ : British Medical Journal.

[12]  I. Goldman,et al.  Resistance to antifolates , 2003, Oncogene.

[13]  Norio Miyaura,et al.  Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds , 1995 .

[14]  R. Schilsky,et al.  Antifolates: the next generation. , 1992, Seminars in oncology.

[15]  E M Berman,et al.  The renewed potential for folate antagonists in contemporary cancer chemotherapy. , 1991, Journal of medicinal chemistry.

[16]  R. M. Hyde,et al.  2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes. , 1987, Journal of medicinal chemistry.

[17]  R. Jackson.  Folate Antagonists as Therapeutic Agents, vol. 1: Biochemistry, Molecular Actions, and Synthetic Design; vol. 2: Pharmacology, Experimental and Clinical Therapeutics , 1985 .

[18]  A. J. Salter,et al.  Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. , 1982, Reviews of infectious diseases.

[19]  M. Ouellette,et al.  New mechanisms of drug resistance in parasitic protozoa. , 1995, Annual review of microbiology.